Compare AbCellera Biologics Inc (ABCL) vs 3M Company (MMM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs 3M Company — how do they compare? AbCellera Biologics Inc trades at $9.2 (market cap $2.99B), while 3M Company trades at $182.16 (market cap $94.44B). The key difference: 3M Company is far larger — about 31.6× AbCellera Biologics Inc's market cap, and 3M Company pays a 1.7% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | MMM | |
|---|---|---|
Market Cap | $2.99B | $94.44B |
Sector | Health | Industrials |
52-Week High | $9.76 | $183.13 |
52-Week Low | $2.78 | $141.10 |
Enterprise Value | $2.58B | $103.67B |
Dividend Yield | — | 1.7% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About 3M Company
3M Company conducts operations in electronics, telecommunications, industrial, consumer and office, health care, safety, and other markets. The Company businesses share technologies, manufacturing operations, marketing channels, and other resources. 3M serves customers worldwide.
Read more on MMM →
